Nasal peanut+ CpG immunotherapy enhances peanut-specific IFN-γ in Th2 cells and IL-10 in non-Th2 cells in mice

Gregory David Sempowski; Brandi T Johnson-Weaver; Greg Sempowski; Herman F Staats

Nasal peanut+ CpG immunotherapy enhances peanut-specific IFN-γ in Th2 cells and IL-10 in non-Th2 cells in mice

Johnson-Weaver, B. T., Sempowski, G. D., & Staats, H. F. (2019). Nasal peanut+ CpG immunotherapy enhances peanut-specific IFN-γ in Th2 cells and IL-10 in non-Th2 cells in mice. Allergy, 74(11), 2220-2223. https://doi.org/10.1111/all.13738

Copy citation

Meet the Experts

View All Experts

Navigate to Greg Sempowski

Greg Sempowski

Recent Publications

Article

Treatment preferences among patients with mild-to-moderate atopic dermatitis

December 31, 2023

Article

Understanding how infection prevention influences nurses' task sequencing using a mixed-methods, simulation-based approach

December 01, 2023

Article

Consensus-based framework for evaluating data modernization initiatives

October 01, 2023

Article

∆8-THC-COOH cross-reactivity with cannabinoid immunoassay kits and interference in chromatographic testing methods

September 15, 2023

View All Publications